Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estimating country-specific cost-effectiveness from multinational clinical trials

R J Willke1, H A Glick, D Polsky

  • 1Pharmacia & Upjohn, Inc., Kalamazoo, MI 49001-0199, USA. richard.j.willke@am.pnu.com

Health Economics
|November 11, 1998
PubMed
Summary

Estimating country-specific cost-effectiveness ratios from multinational clinical trials is crucial for healthcare decision-making. This study presents methods to capture country-specific treatment variations for better resource allocation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melanoma origins: data from early-stage tumours supports de novo and naevus-associated melanomas as distinct subtypes.

The British journal of dermatology·2021
Same author

Global maps of travel time to healthcare facilities.

Nature medicine·2020
Same author

MC1R variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M-SKIP project.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making.

Clinical pharmacology and therapeutics·2016
Same author

Skin cancer risk in BRCA1/2 mutation carriers.

The British journal of dermatology·2014
Same author

Re-examining the BMI threshold for bariatric surgery in the USA.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2014

Area of Science:

  • Health Economics
  • Clinical Trial Analysis
  • Pharmacoeconomics

Background:

  • Healthcare decision-makers require country-specific data due to international variations in treatment costs and outcomes.
  • Multinational clinical trials offer a valuable data source for health economic evaluations.

Purpose of the Study:

  • To propose and illustrate methods for estimating country-specific cost-effectiveness ratios using multinational clinical trial data.
  • To examine the interaction between clinical and economic outcomes in cost-effectiveness analyses.
  • To provide empirical methods for incorporating country-specific variations into treatment effect estimations.

Main Methods:

  • Utilizing data from a multinational phase III clinical trial.
  • Analyzing the interplay of clinical efficacy and economic costs across different countries.

Related Experiment Videos

  • Developing empirical approaches to adjust for country-specific factors in cost-effectiveness calculations.

    • Main Results:

    • Demonstrated that significant country-by-country differences in cost-effectiveness can be identified within multinational trial data.
    • Showcased the practical application of proposed methods using tirilazad mesylate for subarachnoid hemorrhage.

    Conclusions:

    • Country-specific cost-effectiveness estimates derived from multinational trials are feasible and informative.
    • These country-specific findings can significantly aid in national healthcare policy decisions, including reimbursement and utilization strategies.